title: Evaluation and management of patients with isolated neutropenia.
abstract: Neutropenia, defined as an absolute neutrophil count (ANC) <1.5 × 10(9)/L, encompasses a wide range of diagnoses, from normal variants to life-threatening acquired and congenital disorders. This review addresses the diagnosis and management of isolated neutropenia, not multiple cytopenias due to splenomegaly, bone marrow replacement, or myelosuppression by chemotherapy or radiation. Laboratory evaluation generally includes repeat complete blood cell counts (CBCs) with differentials and bone marrow examination with cytogenetics. Neutrophil antibody testing may be useful but only in the context of clinical and bone marrow findings. The discovery of genes responsible for congenital neutropenias now permits genetic diagnosis in many cases. Management of severe chronic neutropenia includes commonsense precautions to avoid infection, aggressive treatment of bacterial or fungal infections, and administration of granulocyte colony-stimulating factor (G-CSF). Patients with severe chronic neutropenia, particularly those who respond poorly to G-CSF, have a risk of eventually developing myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) and require monitoring for this complication, which also can occur without G-CSF therapy. Patients with cyclic, idiopathic, and autoimmune neutropenia have virtually no risk of evolving to MDS or AML. Hematopoietic stem cell transplantation is a curative therapy for congenital neutropenia with MDS/AML or with cytogenetic abnormalities indicating impending conversion.
authors: Departments of Pediatrics and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA. peter.newburger@umassmed.edu
authors: Peter E
authors: PE
authors: Newburger
authors: David C
authors: DC
authors: Dale
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D005820:Genetic Testing; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007958:Leukocyte Count; D009503:Neutropenia / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000628:therapy*
chemical_list: D016179:Granulocyte Colony-Stimulating Factor
references: Pediatr Blood Cancer. 2010 Mar;54(3):465-7
references: 19927291
references: J Clin Invest. 1973 Dec;52(12):3220-30
references: 4750451
references: Blood. 2011 Mar 10;117(10):2764-74
references: 21190991
references: Blood. 1998 Jan 1;91(1):181-6
references: 9414283
references: Ann Intern Med. 2007 Apr 3;146(7):486-92
references: 17404350
references: Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e96-105
references: 19594833
references: Annu Rev Immunol. 2011;29:399-413
references: 21219176
references: J Pediatr. 2012 Apr;160(4):679-683.e2
references: 22050868
references: Blood. 2006 Oct 1;108(7):2182-9
references: 16804117
references: Front Immunol. 2012 Jul 24;3:189
references: 22837758
references: Vox Sang. 2003 Nov;85(4):307-12
references: 14633257
references: Am J Pediatr Hematol Oncol. 1983 Spring;5(1):3-9
references: 6602565
references: Blood. 2012 May 31;119(22):5071-7
references: 22371884
references: Br J Haematol. 2009 Nov;147(4):535-42
references: 19775295
references: Br J Haematol. 2010 Jul;150(2):196-9
references: 20456363
references: Vox Sang. 2005 Jan;88(1):52-9
references: 15663723
references: Blood. 1993 May 15;81(10):2496-502
references: 8490166
references: Nat Genet. 2007 Jan;39(1):86-92
references: 17187068
references: Blood. 1973 Feb;41(2):197-206
references: 4575057
references: Am J Trop Med Hyg. 2011 Oct;85(4):619-25
references: 21976561
references: Pediatr Blood Cancer. 2010 Aug;55(2):314-7
references: 20582973
references: Blood. 2006 Jun 15;107(12):4628-35
references: 16497969
references: Pediatr Blood Cancer. 2007 Oct 15;49(5):609-14
references: 17584878
references: PLoS Genet. 2009 Jan;5(1):e1000360
references: 19180233
references: Curr Opin Hematol. 2009 Jan;16(1):27-34
references: 19057202
references: Curr Opin Hematol. 2011 Nov;18(6):452-60
references: 21912255
references: Br J Haematol. 1973 Jan;24(1):57-644
references: 4715138
references: Transfus Med Rev. 2009 Oct;23(4):266-83
references: 19765516
references: AIDS Rev. 2005 Oct-Dec;7(4):187-96
references: 16425959
references: Immunohematology. 2010;26(1):11-21
references: 20795313
references: Support Cancer Ther. 2006 Jul 1;3(4):220-31
references: 18632498
references: Pediatr Blood Cancer. 2009 Dec;53(6):1068-73
references: 19618456
references: Blood. 2008 May 15;111(10):4954-7
references: 18337561
references: Pediatr Infect Dis J. 2012 Jun;31(6):575-7
references: 22414904
references: N Engl J Med. 2009 Jan 1;360(1):32-43
references: 19118303
references: Blood. 2000 Oct 1;96(7):2317-22
references: 11001877
references: Virus Res. 2006 Aug;119(2):134-45
references: 16545476
references: Blood. 2006 Jul 15;108(2):493-500
references: 16551967
references: Vox Sang. 2008 May;94(4):277-85
references: 18208407
references: Blood. 2007 Dec 15;110(13):4179-87
references: 17761833